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Purpose: The C57BL/6ByJ and BALB/cByJ inbred strains of mice are, respectively, susceptible and resistant to oxygen-
induced retinopathy (OIR). The purpose of this work was to investigate the genetic control of the retinal avascular area
in mouse OIR using a mapping cross.
Methods: The central retinal avascular area was measured on postnatal day 16 (P16) in C57BL/6ByJ, BALB/cByJ, 101
(C57BL/6ByJ x BALB/cByJ)F2, and 116 (BALB/cByJ x C57BL/6ByJ)F2 mice that had been subjected to the OIR
protocol. A genome-wide scan was performed of selected albino and non-albino mice to determine quantitative trait loci
associated with weight and avascular area.
Results: C57BL/6ByJ mice had significantly larger avascular areas than BALB/cByJ ones. Albino mice of the F2
generation had smaller avascular areas than the non-albino mice. Genotyping was performed at 856 informative single
nucleotide polymorphisms approximately evenly distributed across the genome from each of 85 selected F2 mice. Weight,
sex, and the paternal grandmother were found to act as additive covariates associated with the avascular area on P16;
mapping analyses that used a model incorporating these covariates found a quantitative trait locus on chromosome 7
related to avascular area. Mapping analyses that used a model that did not incorporate covariates found a quantitative trait
locus on chromosome 9 related to avascular area. A quantitative trait locus for bodyweight on P16 was mapped to
chromosome 5.
Conclusions: The retinal avascular area in the mouse OIR model is under genetic control. Revascularization in OIR is
related to the weight, strain of paternal grandmother, sex, and albinism. Our data support the existence of a quantitative
trait locus on chromosome 5 that influences weight after exposure to hyperoxia, as well as quantitative trait loci on
chromosomes 7 and 9 that modify susceptibility to OIR.
Retinopathy of prematurity (ROP) is a leading cause of
vision loss in children in both developed and developing
countries [1–3]. ROP is a complex disease where disruption
of normal developmental angiogenesis initially leads to a
persistent avascular phase, which is followed by a phase of
pathological neovascularization. Known risk factors include
the use of supplemental oxygen therapy, low birthweight,
early gestational age at time of birth [4,5], and low serum
levels of insulin-like growth factor 1 [6] and insulin-like
growth factor binding protein 3 (IGFBP3) [7]. Several clinical
investigations have found that rates of severe ROP differ
between ethnic groups even after adjusting for socioeconomic
factors such as access to healthcare, suggesting a heritable
component to ROP development [2,8–10]. Polymorphisms in
the Wnt pathway genes frizzled-4 (FZD4), low-density
lipoprotein receptor-related protein 5 (LRP5), and Norrie
disease protein (NDP) have been associated with individual
cases of severe ROP [11–14]. However, as yet there are no
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genetic factors known to account for a major proportion of
variability in the severity of ROP [10].
Oxygen induced retinopathy (OIR) in the mouse was
developed as a model of ROP [15]. In the mouse OIR model,
exposure to hyperoxia leads to central vaso-obliteration.
When the mice are returned to a normoxic environment, the
region of avascular retina becomes ischemic and creates a pro-
angiogenic milieu that leads to retinal neovascularization
[15,16]. The hyperoxic phase of OIR creates conditions
somewhat similar to those created in the past by overuse of
O2 in the treatment of premature infants. However, hyperoxia
in the OIR model leads to obliteration of central retinal
vessels, while ROP results from the failure of vascularization
of the peripheral retina. The neovascular phases of OIR and
ROP are broadly analogous. When mice that have been
exposed to hyperoxia in the OIR model are returned to
normoxia, the retina gradually revascularizes with vessels that
appear anatomically normal. The initial stages of vascular
regeneration are seen before pathological neovascular tufts
become evident. The study of the revascularization phase of
OIR may be pertinent to understanding retinal angiogenesis
in the preproliferative phase of ROP. For example, a
demonstration that exogenous IGFBP3 increased vessel
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regrowth in OIR was followed by the observation that serum
IGFBP3 correlated with less severe ROP in humans [7].
Interstrain differences in response to OIR models have
been investigated in both mice and rats. Van Wijngaarden
[17] demonstrated that pigmentation status is associated with
the retinal avascular area in crosses between the Fischer 344
and Dark Agouti rat strains. In crosses between these two
strains, retinas from albino animals exposed to OIR were
found to express lower levels of erythropoietin than retinas
from pigmented animals. In further work [18], van
Wijngaarden found that OIR-susceptible rat strains
demonstrated reduced expression of angiogenesis-related
genes in early retinal development than did OIR-resistant rats,
but higher expression of these genes in the proliferative phase
of OIR. Chan et al. [19] performed a similar study comparing
gene expression in retinas of different mouse strains exposed
to the OIR model. Dorrel et al. [20] have shown that the
astrocytes in the retinas of C57BL/6J mice exposed to the OIR
protocol, unlike the astrocytes of BALB/c mice, quickly
degenerate after the mice are returned to normoxia. Although
these strain-specific differences have been found, no previous
study has employed a genome-wide approach to investigate
genetic differences that modify OIR.
This study uses a known difference between BALB/cByJ
and C57BL/6ByJ mice to investigate the genetics of control
of the extent of avascular areas measured four days after
returning to normoxia. These strains were used in a mapping
cross designed to identify quantitative trait loci (QTL) that
modify this phenotype. Since C57BL/6 mice exposed to the
OIR model develop more severe neovascularization, and
revascularize more slowly, than BALB/c mice—despite
having similar vaso-obliterative responses [20]—the
phenotype of the avascular area measured four days after
returning to normoxia is likely to be largely a measure of the
rate of vascular regrowth.
METHODS
Animals: All experimental procedures were approved by the
University of Kansas Medical Center Institutional Animal
Care and Use Committee. BALB/cByJ and C57BL/6ByJ mice
were purchased from Jackson Laboratories (Bar Harbor, ME).
All mice were kept in a 12 h:12 h light-dark cycle with ambient
room temperature between 19 °C and 22 °C. Mice were kept
on a standard diet (8604 rodent diet; Harlan Laboratories,
Indianapolis, IN), and breeding pairs were maintained on a
higher-fat diet (8626 rodent diet; Harlan Laboratories), with
chow and water available ad libitum.
An F2 intercross population was bred using reciprocal
mating strategies (Figure 1). Phenotypes were obtained from
116 (BALB/cByJ x C57BL/6ByJ) F2 and 101 (C57BL/6ByJ
x BALB/cByJ) F2 mice. Values were also obtained from
BALB/cByJ and C57BL/6ByJ mice to confirm their
differential susceptibility to OIR.
Avascular areas in OIR: OIR was induced by exposing pups
to 75% oxygen beginning on P7 and returning them to
normoxia after 120 h. O2 levels in the chambers were
continuously controlled using a ProOx portable monitor
(Biospherix, Redfield, NY), which was calibrated monthly
using room air and 100% O2. Retinas were analyzed 96 h after
their return to hypoxia, since previous unpublished
observations had suggested that at this time point the
interstrain differences were greatest. This experimental plan
allowed genetic modifiers of vascular regeneration to be
investigated. On postnatal day 16 (P16), mice were weighed,
anesthetized with a lethal dose of tribromoethanol delivered
by intraperitoneal injection, perfused with high-molecular
Figure 1. Illustration of the breeding
scheme used in the mapping cross. The
BALB/cByJ and C57BL/6ByJ parental
strains are crossed in both directions.
The resulting F1 mice are inbred through
brother–sister mating to produce the F2
generation. This figure shows the
manner in which the Y chromosomes
and recombined (black and white-
striped) and unrecombined (solid color)
X chromosomes are passed through the
generations of the cross. White
chromosomes are inherited from the
BALB/cByJ albino parent, and black
chromosomes are inherited from the
C57BL/6ByJ pigmented parent. The
different coat colors shown in the F2
generation are for illustrative purposes
only. The color of the F2 animals is
unrelated to either gender or the
direction of the cross.
Molecular Vision 2012; 18:377-389 <http://www.molvis.org/molvis/v18/a41> © 2012 Molecular Vision
378
weight fluorescein isothiocyanate-labeled dextran
(MW≥2,000,000; Sigma, St. Louis, MO) via the left ventricle
to visualize patent vessels, and then enucleated. Tail samples
were taken and stored at −20 °C, and the sex was documented.
Retinas were fixed overnight in 4% paraformaldehyde at
4 °C, dissected, and flatmounted using antifade medium
(Southern Biotech). Immunofluorescent micrographic images
of the retinas were taken using an SMZ 1500 microscope
(Nikon, Tokyo, Japan) and MagnaFire Camera and software
(Optronics, Goleta, CA). ImageJ software was used to
manually trace and measure nonperfused areas. A mean
avascular area was calculated for each mouse using data from
left and right eyes.
DNA preparation and genotype analysis:
Genotyping strategy—Selective genotyping methods
that decrease the cost of genotyping with only minor loss of
information [21–23] were used. For the purpose of selecting
the mice to genotype, the avascular area was adjusted for the
weight of the animals to account for the effect of weight on
the response to OIR. To do this, a correlation coefficient of
−0.1743 mm2/g was determined using linear regression and
multiplied by the weight to create an adjustment factor for
each mouse. Since a significant difference was observed
between the avascular areas of albino and non-albino mice,
these groups were considered separately when choosing mice
to genotype. A group of mice with the smallest adjusted
avascular areas (11 albino and 32 non-albino mice) and a
group with the largest adjusted areas (11 albino and 32 non-
albino mice) were chosen for genotyping.
DNA preparation—DNA was extracted from 0.5 cm
mouse tail samples using the DNEasy Blood and Tissue Kit
(Qiagen, Valencia, CA); concentration and purity (absorbance
ratio at 260/280 nm) were determined using a NanoDrop-1000
spectrophotometer (ThermoFisher Scientific, Waltham, MA).
DNA samples were diluted to 25–150 ng/µl.
Genotype analysis—Genotyping services were
provided by the Center for Inherited Disease Research (Johns
Hopkins University, Baltimore, MD) using a standard linkage
panel containing 856 informative autosomal and X
chromosomal single nucleotide polymorphisms (SNPs;
Mouse Medium Density Linkage Panel; Illumina, San Diego,
CA). For each chromosome, except chromosome X, the most
proximal marker genotyped was within 13.4 Mb of the
centromere; on chromosome X, the most proximal marker was
at 33.5 Mb from the centromere. The most distal marker was
within 5.8 Mb of the telomere for all chromosomes. Internal
markers were no more than 24.6 Mb from each other
(chromosome 1), except on chromosome 2, where two
markers were spaced 64.4 Mb apart. Mean spacing was
approximately 7.88 Mb between markers. Physical distances
quoted in this paper were taken from mouse genome build
37.2, and SNP data were taken from dbSNP Build 128. DNA
samples from each parental strain and one F1 mouse produced
from each direction were used as control samples. Data-
checking analyses suggested by Broman et al. [24] were run
before mapping analysis to ensure the quality and integrity of
both phenotype and genotype data. Due to inconsistencies in
the genotyping results, an albino female mouse from the low
avascular area group was excluded from subsequent analysis.
The genotype of the tyrosinase locus of the mice not
selected for genotyping was inferred from coat color. In this
cross, albinism was conferred by homozygosity for the
BALB/c allele of tyrosinase. The genotype of albino mice at
the tyrosinase locus was encoded as AB/cAB/c. For all non-
albino mice, a code indicating “not-AB/cAB/c” was used.
QTL mapping, identification of covariates: Coat color, sex,
pigmentation and the strain of the paternal grandmother were
tested using ANOVA (ANOVA) models to identify traits
associated with the primary phenotypes of interest (weight
and unadjusted avascular areas). The inclusion of covariates
in mapping analyses reduces residual variation and enhances
QTL detection [24]. Any variable found to have a statistically
significant association was included in mapping models, as
described below.
Linkage analysis: The data were analyzed using R/qtl
software [25]. Initial linkage analysis was performed using
standard interval mapping to determine a logarithm of odds
(LOD) score correlating the genotype with the phenotype for
each marker. The weight and unadjusted avascular area were
analyzed separately as primary phenotypes. Analyses were
also performed using the sex, paternal grandmother,
pigmentation, and weight as covariates. All covariates were
compared as additive and interactive covariates in separate
models to determine the best fit. To account for the multiple
testing inherent in genome-wide QTL studies, and to control
the type I error rate such that the probability of a false positive
over all tests is below some value, significance thresholds
were determined empirically via permutation testing [26]. We
estimated the experiment-wise significance thresholds using
1,000 permutations for each data set, defining the LOD
thresholds for highly-significant QTL (at p<0.05) and
significant QTL (at p<0.1). One thousand permutation
replicates has been shown to be an adequate number for
estimating critical thresholds [26], and is the number routinely
employed in QTL mapping studies.
Gene–gene interactions: Secondary analyses included
composite interval mapping to determine influence of markers
near QTL on other loci (i.e., gene–gene interactions).
Additionally, two dimensional, two-QTL scans were
performed to consider linked or interacting QTL.
Estimating QTL effects: To estimate the contribution of QTL
identified in the linkage analysis, the allelic effects were
calculated and compared between mice categorized by
genotype (AB/cAB/c, AB/cAC57, AC57AC57). Additive and
dominance effects were also considered in calculations. The
QTL effects were assumed to correspond to the SNP marker
nearest the peak LOD score.
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RESULTS
Differences in response to OIR between strains: To confirm
the response of parental strains to the OIR model, 15 BALB/
cByJ offspring from three litters and ten C57BL/6ByJ mice
from three litters were exposed to hyperoxia, as described.
Typical flatmounted fluorescein dextran-perfused retinas are
shown in Figure 2. The measurement of mean retinal
avascular areas on P16 showed C57BL/6ByJ mice to have a
2.9 fold greater unadjusted area than had the BALB/cByJ mice
(1.55 mm2 versus 0.53 mm2, Welch’s two-sample t-test,
p<0.0005).
Weight ranged from 4.15 to 10.95 g. BALB/cByJ mice
weighed more on P16 than did their C57BL/6ByJ counterparts
(with means of 7.64 and 6.05 g, respectively, ANOVA,
p=0.009). After adjusting avascular areas for weight, as
described above, the C57BL/6ByJ mice were still found to
have greater avascular areas than had BALB/cByJ mice
(2.60 mm2 versus 1.86 mm2, ANOVA, p=0.0002, Figure 3),
suggesting that the difference in avascular area was not due
to differences in weight alone.
No differences in unadjusted avascular areas were found
between male and female mice, either within each strain or
across strains (ANOVA, BALB/cByJ, p=0.4, C57BL/6ByJ,
p=0.5; Student’s t-test, all mice: p=0.06). The same was true
when comparing adjusted avascular area between mouse
genders (ANOVA, BALB/cByJ, p=0.07, C57BL/6ByJ,
p=0.15; Student’s t-test, all mice: p=0.08).
Effect of covariates on phenotypes in F2 population: On P16,
weight was investigated as a primary phenotype to identify
potential QTL related to body mass. ANOVA tests were
performed to investigate the correlation of secondary
phenotypes with weight, but no statistically significant
association between weight and the sex, strain of the paternal
grandmother, or coat color was found.
Figure 2. Retinas after oxygen induced
retinopathy (OIR) protocol. A:
Flatmounted retina of a BALB/cByJ
mouse on postnatal day 16 after
exposure to the OIR protocol. The retina
is relatively well vascularized at this
time point. B: A retina from a C57BL/
6ByJ mouse at the same time point after
exposure to the OIR protocol. The
central retina has large areas of
avascularity.
Figure 3. Mean avascular areas of
parental strains after adjusting for
influence of weight. This shows that the
BALB/cByJ strain has smaller areas of
avascular retina in response to
hyperoxia than the C57BL/6ByJ strain
(ANOVA, p=0.0002).
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F2 mice had unadjusted avascular areas ranging from
0.013 to 2.76 mm2, with a mean of 1.06 mm2. On P16, their
mean weight was 6.70 g, with a range from 3.56 to 11.77 g.
Linear regression analysis showed that the avascular area was
inversely associated with weight (ANOVA, p<10−8, Figure 4).
Coat color pigmentation correlated with the adjusted
retinal avascular area. Albino F2 mice exposed to the OIR
model had smaller adjusted avascular areas than had
pigmented mice (ANOVA, p<5×10−8, Figure 5). No
associations between the avascular area and any of the
individual non-albino coat colors were found (ANOVA,
p=0.39).
The strain of the paternal grandmother was associated
with an adjusted avascular area in the F2 generation (ANOVA,
p=0.004). F2 mice produced from inbreeding (BALB/cByJ x
C57BL/6ByJ)F1 parents had smaller avascular areas than had
those produced from the reciprocal cross (2.12 mm2 versus
2.34 mm2). The paternal grandmother was included in the
mapping analysis as an additive covariate. Segregating F2
mice by both the paternal grandmother and sex did not show
any statistically significant differences (ANOVA, p=0.41),
suggesting that the two covariates did not interact.
In the F2 mice, unlike in the parental generation, gender
was associated with the avascular area (the avascular area was
2.16 mm2 for males, 2.28 mm2 for females, ANOVA, p=0.02).
Gender was not found to interact with other secondary
phenotypes such as weight, coat color, or the paternal
grandmother (ANOVA, p=0.08, 0.52, and 0.40, respectively)
in the F2 generation.
ANOVA testing of the weight, paternal grandmother, and
sex did not show any statistically significant interaction
between the covariates (p>0.05). Therefore, they were
included as additive covariates in mapping analyses.
On P16, analyses were performed to identify QTL
potentially related to body mass. ANOVA tests were run to
consider the candidacy of secondary phenotypes as covariates,
but no statistically significant associations between the weight
and the sex, strain of the paternal grandmother, or coat color
were found.
Identification of QTL related to OIR response:
Mapping without covariate inclusion—The initial
QTL analysis employed a covariate-free model. This analysis
identified two LOD score peaks associated with avascular
areas that reached the genome-wide threshold of α=0.05.
These peaks occurred on chromosomes 7 and 9 (Table 1,
Figure 6A). On chromosome 9, the peak LOD score (3.75,
p=0.05, Figure 6B) occurred at SNP rs4135590, located 42.8
Mb distal from the centromere. The genotype at this QTL
explained 6.5% of the variance in avascular areas (p=0.0007,
Table 1), with each BALB/cByJ allele having an additive
protective effect (Figure 6C). The 1.8-LOD support interval
was found to be 12.4–96.0 Mb distal from the centromere.
Figure 4. The inverse association
between avascular area and weight of
F2 mice at postnatal day 16 after
exposure to oxygen-induced
retinopathy. The avascular area was
shown to correlate with weight with a
coefficient of −0.1743. This association
was shown to be statistically significant
(Welch’s two-sample t-test, p<10−8).
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The peak on chromosome 7 was located at SNP
rs13479427, 107.2 Mb distal from the centromere. The LOD
score of this peak was 8.90 (p<0.004). The QTL on
chromosome 7 explained 17.5% of the phenotypic variance
(Table 1, p<0.004). At this locus, the BALB/cByJ allele had
a recessive protective effect. A 1.8-LOD support interval was
determined to lie 81.2–146.5 Mbp distal from the centromere.
The marker at 146.5 Mbp was the most telomeric marker
included in the SNP panel, therefore we are unable to exclude
the possibility that the support interval extends as far as the
telomere.
A two-QTL model including the peaks on chromosome
7 and 9 found that these loci explained 23.2% of the
phenotypic variance (p=1.8×10−11), with a combined LOD
score of 12.4.
Mapping with covariates—Using weight, the strain of
the paternal grandmother, and sex as additive covariates, a
single LOD score peak associated with the unadjusted
avascular area was identified on chromosome 7 at a genome-
wide threshold of α=0.05 (Table 1, Figure 6D). This QTL is
located at 134.2 Mb, between SNPs rs13479506 and
CEL-7_115892950. The LOD score of this peak was 9.83
(p<0.004). The QTL on chromosome 7, in conjunction with
the covariates, explained 34.2% of the phenotypic variance
(Table 1, p<0.004). At this locus, the BALB/cByJ allele had
an additive protective effect (Figure 6E). The 1.8-LOD
support interval was calculated to extend from 88.2 to 146.2
Mb distal from the centromere. The distal boundary of this
interval coincided with the most distal marker tested.
Therefore, it is possible that if a marker at the telomere had
been tested, it would have been found that the interval
extended as far as the telomere.
Locus–locus interactions: Composite interval mapping was
conducted using the genotype at the putative QTL on
chromosome 7 as an additive or interactive covariate with
other loci; this model reduced residual variation to clarify
evidence for further QTL, allowing detection of background
loci with weak main effects [24]. No additional loci were
Figure 5. Comparison of avascular areas
for albino and non-albino F2 mice. The
mean avascular area of albino mice was
found to be 0.67 mm2 versus 1.20 mm2
for non-albino mice, a statistically
significant difference (ANOVA,
p<0.0001).
TABLE 1. QTL ASSOCIATED WITH RETINAL AVASCULAR AREA IN OXYGEN INDUCED RETINOPATHY
Significance Chromosome Phenotype LOD
Score
Markers at or flanking
QTL
Marker
position
(Mb)
LOD support interval (Mb) Effect on
Phenotype
p<0.004 7 Avascular area
(P16)
8.90† rs13479427 107.2
131.8
81.2 – 146.5 0.175
   9.83* rs13479506
CEL-7_115892950‡
135.8 88.2 – 146.5 0.342
p=0.05 9 Avascular area
(P16)
3.75† rs4135590 42.8 12.4 – 96.0 0.065
p=0.05 5 Weight (P16) 3.91† CEL-5_93945748 97.1 52.8 – 133.6 0.041
        † mapping analysis excluded covariates; * mapping analysis included weight, sex, and paternal grandmother as covariates. 
        ‡ the two markers flanking the LOD score peak are reported.
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discovered. A two-dimensional, two-QTL scan was
conducted to identify any epistatic interactions. No
statistically significant linked or multiple QTL were found.
Identification of a QTL related to weight: Standard interval
mapping identified an LOD score peak on chromosome 5 that
reached the genome-wide threshold for high significance
(α=0.05, as determined by permutation tests). The peak
occurred at the SNP CEL-5_9395748, approximately 97.1 Mb
distal from the centromere (LOD=3.91, p=0.024, Figure 7).
On P16, at this locus, the C57BL/6ByJ allele was found to be
associated with greater weight in a dominant fashion. Using
this single-QTL model, the genotype at this locus was
estimated to explain 4.1% of the variance in weight (p=0.01).
A 1.8-LOD support interval was derived using an algorithm
in R/qtl by interpolating between markers on the basis of
recombination frequency, and was found to be 52.8–133.6 Mb
distal from the centromere.
Identification of candidate genes: A list of candidate genes
located within the 1.8-LOD support intervals for the QTL was
created using a web-based virtual positional cloning program,
Positional Medline Database [27], queried March 15, 2011.
The program identifies candidate genes for the LOD support
interval of putative QTL related to keywords. The search
region on chromosome 7 was extended to the telomere (152
Figure 6. The results of genetic linkage
mapping using central retinal avascular
area as the phenotype. A: Linkage map
of avascular area across the whole
genome created using no covariates
(blue) and using weight, paternal
grandmother, and sex as additive
covariates in the analysis (red).
Empirically derived genome-wide
(alpha=0.05) thresholds of significance
are shown as horizontal lines. For
mapping without covariates the
threshold of significance was a
logarithm of odds (LOD) score of 3.75.
For mapping with covariates the
threshold of significance LOD score of
3.81. Mapping without covariates
identified peaks on chromosomes 7
(LOD=8.90) and 9 (LOD=3.75).
Mapping with covariates identifed a
peak on chromosome 7 (LOD=9.83).
B: Linkage map of avascular area across
chromosome 9 created without
inclusion of covariates, showing a peak
at SNP rs4135590 (LOD=3.75, p=0.05).
C: Effect plots of primary peak on
chromosome 9. The BALB/cByJ
allelotype was found to be additively
protective against the development of
OIR. D: Linkage map of avascular area
across chromosome 7 created by
including weight, paternal grandmother,
and sex as additive covariates, showing
a peak between SNPs rs13479506 and
CEL-7_115892950 (LOD=9.83,
p<0.004). E: Effect plot of the peak on
chromosome 7 at the nearest marker,
CEL-7_115892950. The BALB/cByJ
allelotype at this locus is shown to have
a protective effect in a recessive manner.
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Mb); 160 candidate genes were identified in this interval using
“retina AND angiogenesis” as keywords in the query. The ten
genes most-correlated with the search terms were mitogen
activated protein kinase 3 (Mapk3), antigen KI-67 (Mki67),
fibroblast growth factor 4 (Fgf4), fibroblast growth factor
receptor 2 (Fgfr2), insulin-like growth factor 2 (Igf2), tyrosine
hydroxylase (Th), fibroblast growth factor 3 (Fgf3), extra
cellular link domain-containing 1 (Xlkd1), BCL2/adenovirus
E1B interacting protein 3 (Bnip3), and cyclin D1 (Ccnd1).
Using “oxidative stress” as keywords in the query over the
same interval to identify potential candidate genes related
specifically to vaso-obliteration, Positional Medline
identified 231 genes; the top ten included: Mapk3, Th,
Mki67, cytochrome P450 2E1 (Cyp2e1), amyloid beta A4
(Apbb1), parathyroid hormone (Pth), integrin alpha M
(Itgam), integrin alpha L (Itgal), integrin-linked kinase (Ilk),
and Igf2. Twenty-five genes were found within the support
interval of the QTL on chromosome 9 using “retina AND
angiogenesis,” including alpha disintegrin and
metallopeptidase domain 10 (Adam10), chondroitin sulfate
proteoglycan 4 (Cspg4), alpha crystallin B (Cryab),
sphingosine-1-phosphate receptor 2 (Edg5), Pbx/knotted 1
homeobox 2 (Pknox2), erythropoietin receptor (Epor),
dopamine receptor 2 (Drd2), heat shock protein 2 (Hspa2),
cytochrome P450 family 1 subfamily a polypeptide 2
(Hspb2), cytochrome P450 family 1 subfamily a polypeptide
2 (Cyp1a2), and cytochrome P450 family 1 subfamily a
polypeptide 1 (Cyp1a1); “oxidative stress” identified 246
candidates, including kelch-like ECH-associated protein 1
(Keap1), apolipoprotein A-I (Apoa1), beta-site APP cleaving
enzyme 1 (Bace1), Drd2, low density lipoprotein receptor
(Ldlr), intercellular adhesion molecule 1 (Icam1), cytochrome
P450 family 19 subfamily a polypeptide 1 (Cyp19a1),
amyloid beta (A4) precursor-like protein 2 (Aplp2), Cyp1a2
and Cyp1a1. For the support interval found on chromosome
5 using weight as the primary phenotype, “birth weight” was
used as the keyword in the query to derive 101 candidate
genes, including scavenger receptor class B, member 1
(Scarb1), alpha fetoprotein (Afp), group specific component
(Gc), chemokine (C-X-C motif) ligand 2 (Cxcl2), heparanase
(Hpse), chemokine (C-X-C motif) ligand 1 (Cxcl1), casein
beta (Csn2), amphiregulin (Areg), platelet factor 4 (Pf4 or
Cxcl4), and chemokine (C-X-C motif) ligand 10 (Cxcl10).
DISCUSSION
ROP remains a significant cause of vision loss in the pediatric
population. Although some risk factors have been identified,
its development is complex and involves both environmental
and genetic factors. This study aimed to initiate the
identification of genes that may play a role in ROP
Figure 7. The results of genetic linkage
mapping using bodyweight 96 h after
exposure to hyperoxia as the phenotype.
A: A genome-wide linkage map of
weight on postnatal day 16 after
exposure to the oxygen-induced
retinopathy model. The threshold of
significance was found to be 3.86
(α=0.05), as determined by permutation
tests. B: Shows linkage across
chromosome 5, with significant linkage
at marker CEl-5_93945748
(LOD=3.91, p=0.024). C: Effect plot of
genotypes at this marker on postnatal
day 16; homozygosity for the BALB/
cBJ allelotype at this locus is associated
with reduced weight in a recessive
manner (ANOVA, p<0.001). The
BALB/cByJ allele is designated AB/c,
and the C57BL/6ByJ alleles is
designated AC57.
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susceptibility. Using the murine OIR model, we developed a
mapping cross between C57BL/6ByJ and BALB/cByJ inbred
mouse strains. These mice were confirmed to have
significantly different vascular responses to OIR on P16, with
the BALB/cByJ strain having smaller avascular areas than the
C57BL/6ByJ strain. These results support those published by
Dorrell, et al. [20], which found that while both strains have
similar vaso-obliterative areas upon their return to normoxia
on P12, the BALB/cByJ strain revascularizes more rapidly
than the C57BL/6J strain.
Genetically determined differences in retinal ocular
morphology between the two strains may play a role in their
responses to OIR. Recent reports using confocal scanning
laser ophthalmoloscopy confirm physiologic differences in
retinal structure between adult C57BL/6J and BALB/c mice,
with BALB/c mice having significantly thinner central retinas
(211 μm versus 237 μm) [28]. The differences between
C57BL/6J and BALB/c mice are at least partially related to
C57BL/6J being a pigmented strain, while BALB/c is an
albino strain [29–31], and this issue is discussed further below.
The mapping cross revealed QTL associated with
susceptibility to OIR on chromosomes 7 and 9. The BALB/
cByJ allele of the chromosome 7 QTL was found to be
protective in a recessive manner. In a mapping model that
includes weight, sex, and the paternal grandmother as additive
covariates, the allelotype at this marker is estimated to explain
34% of the phenotypic variation. The BALB/cByJ allele of
the chromosome 9 QTL was also found to be protective in a
recessive manner; this peak only reached statistical
significance when covariates were excluded from the model.
In a single QTL model, this allele was estimated to explain
7% of the variation in phenotype.
No QTL was identified on the X chromosome, despite
evidence that the strain of the paternal grandmother was
associated with the avascular area. It was noted that when
initially performing mapping analyses with single covariates
to confirm their inclusion in the final model, the inclusion of
the paternal grandmother alone caused a loss of the peak on
chromosome 9. This suggests that the directionality of the
cross may influence susceptibility via an epigenetic effect on
a gene or genes within this locus, rather than through a
modifier gene on the X chromosome.
A QTL related to weight on P16 was identified on
chromosome 5. The C57BL/6ByJ allele was found to be
associated with greater weight in a dominant manner; the
genotype at this locus was estimated to explain 4.1% of the
variance in weight at this time point. The selective genotyping
model based on avascular area, rather than weight, may have
introduced bias in estimating the effect of this QTL on weight
and avascular area. In both human ROP and murine OIR,
increased birthweight and subsequent weight gain are
protective against neovascularization [32,33]; although
C57BL/6ByJ mice had larger avascular areas on P16 than had
their BALB/cByJ counterparts, the data suggest that the
C57BL/6ByJ genome does contain an allele related to weight
that serves to protect against OIR.
The initial analysis of F2 mice revealed significantly
different retinal avascular areas in albino and non-albino mice.
This result supports findings from a rat backcross [17] as well
as across different strains of rats [34]. Because albinism in this
cross is caused by the homozygous loss of function of
tyrosinase, the rate-limiting enzyme in the biosynthesis of
melanin [31], these data suggest that tyrosinase or a linked
gene might play a role in disease susceptibility. The QTL
identified on chromosome 7 by mapping analysis includes
tyrosinase (located at 94.58–94.64 Mb) within the 1.8-LOD
support interval. An intriguing possibility is that tyrosinase
itself is a modifier of the area of the avascular retina in rodent
OIR.
The tyrosinase gene has various roles in ocular
physiology. There are numerous morphological differences
between the retinas of albino and non-albino mice, and it is
not clear whether these may be associated with responses to
hyperoxia. It is possible that the thicker C57BL/6 retina
becomes more hypoxic than the BALB/c retina, and that this
leads to greater astrocyte degeneration and slower
revascularization [29–31]. The absence of melanin in the
retinal pigment epithelium may alter the response of the retina
to oxidative stress [17]. Alternatively, since the absence of
melanin in the iris increases the amount of light reaching the
retina [35], it is possible that greater retinal light exposure
affects the revascularization process, even though light has
not previously been demonstrated to play a role in modifying
the severity of OIR [36]. Furthermore, tyrosinase can form
L-3,4-dihydroxyphenylalanine (L-dopa), the immediate
precursor of dopamine [37]. The role of dopamine metabolism
in OIR is currently unknown, but dopamine is known to
modulate tumor angiogenesis [38], and may play a role in
angiogenesis in OIR. Since albinism interacts with retinal
physiology in many ways, we are performing further
experiments to investigate the candidacy of tyrosinase.
However, neither our experiment nor the work that found an
association between albinism and OIR in rats [17] were
designed to test the candidacy of any particular gene.
Positional Medline identified several other interesting
candidate genes, located within the support interval of the
QTL on chromosome 7, using the keywords “retina AND
angiogenesis.” MAPK3, or ERK-1, is a mitogen-activated
kinase that is activated by fibroblast growth factor (FGF) to
induce endothelial cell proliferation in retinal angiogenesis
[39], and has been shown to play a role in regulating VEGF
expression in response to oxidative stress [40]. FGF4, a
member of the FGF family, is a mitogen that is involved in
the development and morphogenesis of various cell and tissue
types [41]. Overexpression of FGFR2, a receptor for FGF, has
been demonstrated in several types of neoplasia, including
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breast cancer [42], prostate cancer [42], renal cell carcinoma
[43], and gastric cancer [44]. Within the retina, insulin-like
growth factor 2 is present almost exclusively in the
photoreceptors and vasculature, where it is the major locally
expressed growth factor. However, it is not expressed in the
vascular endothelial cells in the neovascular tufts formed in
response to OIR [45]. Tyrosine hydroxylase is the enzyme
primarily responsible for dopamine production in the central
nervous system and retina; in the eye, it is found primarily in
amacrine cells in the inner plexiform layer [46]. Xlkd1, or
extra-cellular link domain containing 1, encodes a hyaluronan
receptor expressed on the lymphatic endothelium in both adult
and embryonic vessels, and XLKD1-positive cells were
recently identified in the hyaloid vascular system of the
developing murine eye [47].
Four of the top ten putative genes identified by using the
key terms “oxidative stress” (Mapk3, Th, Mki67, and Igf2)
were also identified in the prior search. Integrin alphas L, and
M (CD11a and b, respectively) are expressed on neutrophils,
and when complexed with beta-2 integrin CD18, function to
modulate the migration of the cells to the site of the injury by
binding intracellular adhesion molecule 1 (ICAM1) on
endothelial cells [48]. VEGF-A has been shown to stimulate
neutrophil and T-cell recruitment in an ITGAL- and ITGAM-
dependent manner [49]. Integrin-linked kinase (ILK)-
signaling has been shown to mediate the production of the
brain-derived neurotrophic factor by endothelial cells [50],
and oxidative stress disrupts this signaling pathway [51].
Although ranked less highly by the Positional Medline
algorithm, three genes related to Wnt signaling pathways were
included in the list of candidate genes. Wnt signaling plays an
essential role in cell survival, proliferation, and migration, and
has an important role in controlling both developmental
retinal angiogenesis and retinal neovascularization in disease
states [52]. Mutations in genes related to this pathway have
been implicated in several ocular neovascular diseases with
phenotypic similarities to ROP, including familial exudative
vitreoretinopathy and Norrie disease [53]. Frizzled-4 (FZD4)
is a Wnt receptor that functions in both canonical and
noncanonical signaling pathways. Mutations in FZD4 have
been identified as a cause of familial exudative
vitreoretinopathy [54] and have been confirmed in cases
worldwide [55,56]. More recently, FZD4 mutations have been
found in a small number (3%) of a cohort of infants with severe
ROP [11]. Interestingly, the mouse Fzd4 gene lies within the
QTL found on chromosome 7. Wnt11 is another gene involved
in Wnt signaling that is encoded within the QTL on
chromosome 7; WNT11 is a noncanonical ligand in the
pathway. Within the retina specifically, mutations in Wnt11
have been shown to result in increased angiogenesis and
branching [57]. Dickkopf 3 (DKK3) belongs to a family of
secreted glycoproteins that act as regulators of Wnt signaling.
In the retina, Dkk3 is expressed by Müller glia and retinal
ganglion cells, and is a cell type-specific positive regulator of
Wnt signaling. In response to photoreceptor death in a murine
model of retinal degeneration, Dkk3 expression was
upregulated, and functioned to inhibit caspase activation in
Müller glia [58].
The LOD support interval on chromosome 9 also contains
several interesting candidates identified by Positional
Medline, related to the retina and angiogenesis. Chondroitin
sulfate proteoglycan 4 (CSPG4), also known as NG2, is
expressed by nascent pericytes early in angiogenesis. Studies
of ischemic retinal neovascularization have shown decreased
ectopic vessel protrusion into the vitreous, and decreased
proliferation of both pericytes and endothelial cells in NG2
knockout (KO) mice [59]. Similarly to MAPK3, MAP2K1
(MEK1) mediates FGF-stimulated endothelial-cell
proliferation in tumor models [39]. IL18 has been shown to
play a role in regulating the regression of pathological
neovascularization in mice after their exposure to the OIR
model [60]; additional studies using KO mice suggest that
IL18 plays a role in regulation of retinal vessel formation
[61]. Crystalline alpha B is a chaperone within the small heat-
shock protein family and has been shown, using KO mouse
models, to play a role in intraocular angiogenesis by acting as
a chaperone for VEGF-A [62]. Erythropoietin (EPO) has been
linked to both ROP and diabetic retinopathy. Local tissue EPO
levels are suppressed during retinal vessel loss in OIR and
elevated during neovascularization, and the pharmacological
use of EPO has been shown to protect against hypoxia-
induced apoptosis [63]. The siRNA inhibition of EPO
expression during the neovascular phase of OIR has been
shown to inhibit neovascularization [64]. Human and murine
studies have both found that vitreal EPO expression is
associated with proliferative diabetic retinopathy [65].
Candidates derived using the key terms “oxidative stress”
included several adhesion molecules. ICAM1 is expressed by
endothelial cells and plays a critical role in leukocyte stasis
and migration to the injury site [66]. Dopamine receptor 2 acts
as an antioxidant at physiologic concentrations of dopamine;
it has been found to regulate the production of reactive
oxidative species, and KO mice have higher blood pressure in
part due to the increased oxidative damage in the kidney
[67]. The low-density lipoprotein receptor is also involved in
mediating oxidative stress; KO mouse models have increased
oxidative stress, inflammation, and atherosclerosis [68].
Furthermore, oxidative modification of this receptor has been
associated with endothelial cell dysfunction [69]. Three
different cytochrome P450 genes were also found to be
candidates by the Positional Medline program; however, this
may be a spurious result due to the large amount of data
published regarding oxidative stress generated in the
metabolism of various drugs.
The support interval of the QTL on chromosome 5
associated with weight includes 101 candidate genes related
to “birth weight.” Low maternal serum α-fetoprotein (AFP)
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levels have been shown in humans to be associated with high
birthweight infants [70]. Heparanase, HPSE, plays a role in
placental development and affects both structure and nutrient
transport [71]. CXCL1, 2, 4, and 10 are chemokines that have
been studied extensively in regard to their role in
inflammation [72,73], development [73], angiogenesis [73,
74], and neoplasia [74].
In conclusion, revascularization in OIR is related to the
weight, strain of paternal grandmother, sex, and albinism. Our
data support the existence of a QTL on chromosome 5 that
influences weight after exposure to hyperoxia, as well as QTL
on chromosomes 7 and 9 that modify susceptibility to OIR.
Ongoing studies are investigating the role of candidate
quantitative trait genes as modifiers of the progression of OIR.
It is hoped that investigation of quantitative trait genes will
help to elucidate the pathogenesis of ROP. These modifier
genes may also be candidates for susceptibility genes in other
complex ocular diseases involving aberrant angiogenic
responses, such as diabetic retinopathy and neovascular age-
related macular degeneration.
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